78 FR 128 pg. 40146 - Notice of Meeting
Type: NOTICEVolume: 78Number: 128Page: 40146
Page: 40146FR document: [FR Doc. 2013-15733 Filed 7-2-13; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Agency for Healthcare Research and Quality
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY:
Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION:
Notice of one AHRQ Subcommittee Meetings by Virtual Review.
SUMMARY:
The subcommittee listed below is part of AHRQ's Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at this meeting. This meeting will be closed to the public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C. section 552b(c)(4), and 5 U.S.C. section 552b(c)(6).
Name of Subcommittee: Health Care Research Training Virtual Review.
Date: July 11, 2013 (Open from 9:00 a.m. to 9:30 a.m. on July 11 and closed for remainder of the meeting).
Place: Agency for Healthcare Research and Quality, John Eisenberg Building, 540 Gaither Road, OEREP Conference Room, Rockville, MD 20850.
FOR FURTHER INFORMATION CONTACT:
(To obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting.)
Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427-1554.
SUPPLEMENTARY INFORMATION:
In accordance with section 10 (a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the scientific peer review groups listed above, which are subcommittees of AHRQ's Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meeting are subject to change as priorities dictate.
Dated: June 20, 2013.
Carolyn M. Clancy,
Director.
[FR Doc. 2013-15733 Filed 7-2-13; 8:45 am]
BILLING CODE 4160-90-M